2013 JSM best contributed poster award winners
1 - Li Wang and Weihua Tang, Bristol-Myers Squibb
Meta Analysis for All-cause Death for Apixaban vs. Placebo Or Control in SPAF Trials
2 - Jianing Di, Xin Zhao, Daniel Wang, Ming Lu, and Michael Krams, Janssen Research & Development
Assessing the Cumulative Exposure Response in Alzheimer Disease Studies
3 - Kelly H. Zou, Ching-Ray Yu, Ye Tan, and Martin O. Carlsson, Pfizer Inc.
Comparative Effectiveness Research Using Meta-Analysis to Evaluate and Summarize Diagnostic Accuracy
2012 JSM Biopharm Poster Awards
1 - Junxiang Luo and Yongming Qu
Comparison of Negative Binomial Regression Models in Analyzing Hypoglycemia Events
2 - David Kerr and Shannon Grant
Creating a Better, Shorter DMC Report: A Stack of Needles, Not a Needle in a Haystack
3 - Alexandra I. Barsdorf, Kelly H. Zou, Martin O. Carlsson, and Joseph C. Cappelleri
Methods for Responder Analysis of Patient-Reported Outcomes
2011 Biopharmaceutical Section Student Paper Awards
1 - Kelley Kidwell, University of Pittsburgh
Weighted Log-rank Statistic to Compare Shared-Path Adaptive Treatment Strategies
2 - Jonathan Yabes, University of Pittsburgh
Semiparametric Estimation in the Proportional Subdistribution Hazards Model with Missing Cause of Failure
3 - Chunyan Cai, TexasMD Anderson Cancer Center
Bayesian Adaptive Phase II Screening Design for Combination Trials
Honorable Mention - Layla Parast, Harvard University
Landmark Estimation of Survival Incorporating Intermediate Event Information in a Randomized Clinical Trial
2011 Biopharmaceutical Section Best Contributed Paper Award
1 - Christopher Tong, U.S. Department of Agriculture
Concordance Correlation Coefficient Decomposed into the Product of Precision and Accuracy
2 - Gang Chen, Johnson & Johnson Pharmaceutical R&D
Design and Operational Issues in Clinical Trials with Adaptive Design
3 - Radha Railkar, Merck & Co.
An Overview of Different Methods to Assess Agreement in Early Phase Clinical Trials
Honorable Mention - Paul Schuette, U.S. Food and Drug Administration/CDER
Confidence Intervals for Binomial Proportions with Applications to Product Safety Signaling in Drug Exposure Registries